MX2010004733A - Granulacion en humedo utilizando un agente secuestrante de agua. - Google Patents
Granulacion en humedo utilizando un agente secuestrante de agua.Info
- Publication number
- MX2010004733A MX2010004733A MX2010004733A MX2010004733A MX2010004733A MX 2010004733 A MX2010004733 A MX 2010004733A MX 2010004733 A MX2010004733 A MX 2010004733A MX 2010004733 A MX2010004733 A MX 2010004733A MX 2010004733 A MX2010004733 A MX 2010004733A
- Authority
- MX
- Mexico
- Prior art keywords
- wet granulation
- sequestering agent
- water sequestering
- water
- trimethoxyphenylamino
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/538—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with carbocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
Abstract
Se describen tabletas que comprenden formulaciones estables hidrolíticamente de sal disódica de (6-(5-flúor-2-(3,4,5-trimetoxi fenilamino)pirimidin-4-ilamino)-2,2-dimetil- 3-oxo-2H-pirido[3,2-b ] [1,4]oxazin-4(3H)-il)metil fosfato (compuesto 1) preparado por un proceso de granulación en húmedo.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US98623707P | 2007-11-07 | 2007-11-07 | |
PCT/US2008/082618 WO2009061909A2 (en) | 2007-11-07 | 2008-11-06 | Wet granulation using a water sequestering agent |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2010004733A true MX2010004733A (es) | 2010-06-25 |
Family
ID=40623940
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2010004733A MX2010004733A (es) | 2007-11-07 | 2008-11-06 | Granulacion en humedo utilizando un agente secuestrante de agua. |
Country Status (34)
Country | Link |
---|---|
US (3) | US8263122B2 (es) |
EP (1) | EP2217241B1 (es) |
JP (1) | JP5567487B2 (es) |
KR (2) | KR20150129067A (es) |
CN (1) | CN101998857A (es) |
AU (1) | AU2008323938B2 (es) |
BR (1) | BRPI0820389A2 (es) |
CA (1) | CA2704474C (es) |
CO (1) | CO6280491A2 (es) |
CR (1) | CR11476A (es) |
CU (1) | CU23915B1 (es) |
CY (1) | CY1122163T1 (es) |
DK (1) | DK2217241T3 (es) |
DO (1) | DOP2010000136A (es) |
EA (1) | EA020210B1 (es) |
EC (1) | ECSP10010233A (es) |
ES (1) | ES2672519T3 (es) |
HN (1) | HN2010000930A (es) |
HR (1) | HRP20181174T1 (es) |
HU (1) | HUE039193T2 (es) |
IL (1) | IL205204A (es) |
LT (1) | LT2217241T (es) |
MX (1) | MX2010004733A (es) |
MY (1) | MY169761A (es) |
NI (1) | NI201000078A (es) |
NZ (1) | NZ585913A (es) |
PL (1) | PL2217241T3 (es) |
PT (1) | PT2217241T (es) |
RS (1) | RS57525B1 (es) |
SG (1) | SG185961A1 (es) |
SI (1) | SI2217241T1 (es) |
TR (1) | TR201807879T4 (es) |
UA (1) | UA102825C2 (es) |
WO (1) | WO2009061909A2 (es) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20080223392A1 (en) * | 2007-03-14 | 2008-09-18 | L'oreal | Process for relaxing or straightening hair |
GB0814688D0 (en) | 2008-08-12 | 2008-09-17 | Knauf Insulation | Thermal insulation product |
AU2010290829A1 (en) * | 2009-09-07 | 2012-04-26 | Douglas Robert Cleverly | Granulated anthelmintic preparations and delivery systems |
JP2013520501A (ja) * | 2010-02-24 | 2013-06-06 | オースペックス ファーマシューティカルズ,インク. | チロシンキナーゼのトリメトキシフェニルインヒビター |
ES2710423T3 (es) * | 2011-07-28 | 2019-04-25 | Rigel Pharmaceuticals Inc | Formulaciones de (trimetoxifenilamino) pirimidinilo nuevas |
WO2016172053A1 (en) | 2015-04-24 | 2016-10-27 | Rigel Pharmaceuticals, Inc. | Methods of treating ibrutinib-resistant disease |
CA2937365C (en) | 2016-03-29 | 2018-09-18 | F. Hoffmann-La Roche Ag | Granulate formulation of 5-methyl-1-phenyl-2-(1h)-pyridone and method of making the same |
US20210077479A1 (en) | 2017-08-30 | 2021-03-18 | Acadia Pharmaceuticals Inc. | Formulations of pimavanserin |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4904477A (en) * | 1987-07-08 | 1990-02-27 | American Home Products Corporation | Spray dried ibuprofen compositions |
US5763172A (en) * | 1992-01-21 | 1998-06-09 | Board Of Regents, The University Of Texas System | Method of phosphate ester hydrolysis |
US5358652A (en) * | 1992-10-26 | 1994-10-25 | Ethyl Petroleum Additives, Limited | Inhibiting hydrolytic degradation of hydrolyzable oleaginous fluids |
WO1999033846A2 (en) * | 1997-12-31 | 1999-07-08 | The University Of Kansas | Water soluble prodrugs of secondary and tertiary amine containing drugs and methods of making thereof |
US6238677B1 (en) * | 1998-08-18 | 2001-05-29 | The United States Of America As Represented By The Secretary Of Agriculture | Starch microcapsules for delivery of active agents |
US6716453B1 (en) * | 1999-05-20 | 2004-04-06 | Verion, Inc. | Method for increasing the active loading of compressible composition forms |
TWI329105B (en) * | 2002-02-01 | 2010-08-21 | Rigel Pharmaceuticals Inc | 2,4-pyrimidinediamine compounds and their uses |
JP2005526095A (ja) * | 2002-03-20 | 2005-09-02 | エラン ファーマ インターナショナル,リミティド | 脆砕性の低い急速溶解投与剤型 |
US20060018972A1 (en) * | 2002-11-26 | 2006-01-26 | Upm Pharmaceuticals, Inc. | Aqueous sustained-release drug delivery system for highly water-soluble electrolytic drugs |
ITMI20040498A1 (it) * | 2004-03-16 | 2004-06-16 | Solvay Solexis Spa | Composizioni granulari |
ATE451381T1 (de) * | 2005-01-19 | 2009-12-15 | Rigel Pharmaceuticals Inc | Prodrugs aus 2,4-pyrimidindiamin-verbindungen und ihre verwendungen |
US8227455B2 (en) * | 2005-04-18 | 2012-07-24 | Rigel Pharmaceuticals, Inc. | Methods of treating cell proliferative disorders |
AU2010286354A1 (en) * | 2009-08-31 | 2012-04-19 | Depomed, Inc. | Gastric retentive pharmaceutical compositions for immediate and extended release of acetaminophen |
WO2012064377A1 (en) * | 2010-03-29 | 2012-05-18 | Chelsea Therapeutics, Inc. | Antifolate compositions |
-
2008
- 2008-11-06 MY MYPI2010001805A patent/MY169761A/en unknown
- 2008-11-06 LT LTEP08848427.4T patent/LT2217241T/lt unknown
- 2008-11-06 AU AU2008323938A patent/AU2008323938B2/en active Active
- 2008-11-06 KR KR1020157031730A patent/KR20150129067A/ko not_active Application Discontinuation
- 2008-11-06 CA CA2704474A patent/CA2704474C/en active Active
- 2008-11-06 HU HUE08848427A patent/HUE039193T2/hu unknown
- 2008-11-06 US US12/266,337 patent/US8263122B2/en active Active
- 2008-11-06 WO PCT/US2008/082618 patent/WO2009061909A2/en active Application Filing
- 2008-11-06 PT PT88484274T patent/PT2217241T/pt unknown
- 2008-11-06 SI SI200831981T patent/SI2217241T1/sl unknown
- 2008-11-06 UA UAA201006878A patent/UA102825C2/ru unknown
- 2008-11-06 TR TR2018/07879T patent/TR201807879T4/tr unknown
- 2008-11-06 EA EA201070570A patent/EA020210B1/ru not_active IP Right Cessation
- 2008-11-06 BR BRPI0820389-0A patent/BRPI0820389A2/pt not_active Application Discontinuation
- 2008-11-06 MX MX2010004733A patent/MX2010004733A/es active IP Right Grant
- 2008-11-06 NZ NZ585913A patent/NZ585913A/en unknown
- 2008-11-06 EP EP08848427.4A patent/EP2217241B1/en active Active
- 2008-11-06 CN CN2008801195118A patent/CN101998857A/zh active Pending
- 2008-11-06 PL PL08848427T patent/PL2217241T3/pl unknown
- 2008-11-06 SG SG2012081980A patent/SG185961A1/en unknown
- 2008-11-06 JP JP2010532340A patent/JP5567487B2/ja active Active
- 2008-11-06 KR KR1020107012273A patent/KR101663838B1/ko active IP Right Grant
- 2008-11-06 DK DK08848427.4T patent/DK2217241T3/en active
- 2008-11-06 ES ES08848427.4T patent/ES2672519T3/es active Active
- 2008-11-06 RS RS20180851A patent/RS57525B1/sr unknown
-
2010
- 2010-04-19 IL IL205204A patent/IL205204A/en active IP Right Grant
- 2010-05-05 CU CU2010000089A patent/CU23915B1/es not_active IP Right Cessation
- 2010-05-06 HN HN2010000930A patent/HN2010000930A/es unknown
- 2010-05-06 NI NI201000078A patent/NI201000078A/es unknown
- 2010-05-06 DO DO2010000136A patent/DOP2010000136A/es unknown
- 2010-06-03 CR CR11476A patent/CR11476A/es not_active Application Discontinuation
- 2010-06-04 CO CO10067826A patent/CO6280491A2/es not_active Application Discontinuation
- 2010-06-04 EC EC2010010233A patent/ECSP10010233A/es unknown
-
2012
- 2012-07-26 US US13/559,097 patent/US8372415B2/en active Active
-
2013
- 2013-01-10 US US13/738,458 patent/US8652492B2/en active Active
-
2018
- 2018-07-20 HR HRP20181174TT patent/HRP20181174T1/hr unknown
- 2018-07-24 CY CY20181100772T patent/CY1122163T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2010004733A (es) | Granulacion en humedo utilizando un agente secuestrante de agua. | |
TN2012000146A1 (fr) | Derives de pyrrolo[2,3-d]pyrimidine | |
MA32341B1 (fr) | Dérivés de 3h- [1, 2, 3] triazolo [4, 5, d] pyrimidine, leur utilisation comme inhibiteurs de la kinase mtor et de la kinase pi3, et leurs synthèses | |
NZ553405A (en) | Nucleoside phosphonate conjugates as anti-HIV agents | |
TW200740815A (en) | P38 MAP kinase inhibitors and methods for using the same | |
GEP20125658B (en) | Imidazotriazines and imidazo pyrimidines as kinase inhibitors | |
MY160110A (en) | Composition comprising tetracyclic compound | |
SI2056832T1 (sl) | Sestavki, primerni za oralno administracijo, ki vsebujejo derivat triazolo(4,5-D) pirimidina | |
NZ629807A (en) | Novel pyrrolopyrimidine compounds as inhibitors of protein kinases | |
MX2009002772A (es) | Uso de 2-6-(3-amino-piperidin-1-il)-3-metil-2,4-dioxo-3,4-dihidro- 2h-pirimidin-1-ilmetil-4-fluoro-benzonitrilo. | |
AR087546A1 (es) | Hemifumarato de tenofovir alafenamida | |
MX2009009703A (es) | Preparacion solida que comprende 2-[[6-[(3r)-3-amino-1-piperidinil ]-3,4-dihidro-3-metil-2,4-dioxo-1(2h)-pirimidinil]metil]-4-fluoro benzonitrilo. | |
UA83091C2 (en) | Pyrido[2,3-d]pyrimidine-2,4-diamines as pde 2 inhibitors | |
MX2010008686A (es) | Derivado de pirrolopirimidina como inhibidor de fosfatidilinositol 3-quinasa y uso del mismo. | |
TW200621792A (en) | Process for the preparation of bisphosphonates | |
MX2007013624A (es) | Inhibidores de proteina cinasa. | |
TN2009000362A1 (en) | Weekly administration of dipeptidyl peptidase inhibitors | |
EA200970669A1 (ru) | Производные 2-амино-5,7-дигидро-6н-пирроло[3,4-d]пиримидина в качестве ингибиторов hsp-90, предназначенные для лечения рака | |
NZ594214A (en) | Tablets comprising cobicistat, elvitegravir, emtricitabine and tenofovir disoproxil fumarate for combination therapy | |
PL2094308T3 (pl) | Trwały preparat pozajelitowy zawierający inhibitor RSV o strukturze benzodiazepiny | |
MX2009005664A (es) | D-isoglutamil-d-triptofano cristalino, y la sal monoamonica de d-isoglutamil-d-triptofano. | |
UA83900C2 (en) | Amorphous forms of risedronate monosodium | |
IL195837A0 (en) | 4-amino-3-arylamino-6-arylpyrazolo[3,4-d] | |
EA200802248A1 (ru) | Способы применения соединений 4-амино-5-хлортиено[2,3-d]-пиримидина в качестве инсектицидов | |
HUP0400891A2 (en) | 7h-pyrrolo[2,3-d]pyrimidine derivatives, their pharmaceutically acceptable salts, pharmaceutical compositions containing them and process for the production of the compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
GD | Licence granted | ||
FG | Grant or registration |